Fineotex Chemical Share Price
44.82+0.00 (-0.49%)
+82.05% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
SOLARINDSNSE
PIDILITINDNSE
SRFNSE
FLUOROCHEMNSE
GODREJINDNSE
AETHERNSE
DEEPAKNTRNSE
DEEPAKFERTNSE
FINEORGNSE
FCLNSE
Fineotex Chemical Share Price
44.82+0.00 (-0.49%)
+82.05% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| 22% | 29% | 14% | 45% |
| 20% | 21% | 7% | 14% |
| 33% | 30% | 12% | 82% |
| 21% | 24% | 22% | 16% |
Peer Comparison
Symbol
SOLARINDS
PIDILITIND
SRF
FLUOROCHEM
NAVINFLUOR
GODREJIND
AETHER
DEEPAKNTR
DEEPAKFERT
FINEORG
FCL
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 18,649 | ₹170574 Cr | 75.36 | 68.18 | 283.5 | ₹1678 Cr |
| 1,584.9 | ₹160623 Cr | 59.84 | 6.03 | 30.24 | ₹2449 Cr |
| 2,524.3 | ₹74490 Cr | 32.63 | 17.18 | 106.98 | ₹1835 Cr |
| 4,957 | ₹54764 Cr | 80.65 | 22.09 | 97.5 | ₹577 Cr |
| 10,203 | ₹52333 Cr | 57.47 | 52.48 | 208.91 | ₹664 Cr |
| 1,090.35 | ₹37074 Cr | 24.84 | 16.61 | 60.64 | ₹1241 Cr |
| 1,678.5 | ₹22515 Cr | 90.34 | 5.12 | 24.71 | ₹219 Cr |
| 1,547.8 | ₹21197 Cr | 19.96 | 29.15 | 96.58 | ₹551 Cr |
| 1,438 | ₹18369 Cr | 15.77 | 31.19 | 125.33 | ₹737 Cr |
| 5,495 | ₹16731 Cr | 34.73 | 49.62 | 176.69 | ₹417 Cr |
| 44.96 | ₹5248 Cr | 40.19 | 0.29 | 1.27 | ₹109 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 | Dec 2019 | Sep 2019 | Jun 2019 | Mar 2019 | Dec 2018 | Sep 2018 | Jun 2018 | Mar 2018 | Dec 2017 | Sep 2017 | Jun 2017 | Mar 2017 | Dec 2016 | Sep 2016 | Jun 2016 | Mar 2016 | Dec 2015 | Sep 2015 | Jun 2015 | Mar 2015 | Dec 2014 | Sep 2014 | Jun 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹388 Cr | ₹377 Cr | ₹314 Cr | ₹184 Cr | ₹138 Cr | ₹137 Cr | ₹120 Cr | ₹126 Cr | ₹146 Cr | ₹142 Cr | ₹153 Cr | ₹138 Cr | ₹145 Cr | ₹132 Cr | ₹138 Cr | ₹109 Cr | ₹134 Cr | ₹136 Cr | ₹121 Cr | ₹105 Cr | ₹78 Cr | ₹63 Cr | ₹75 Cr | ₹58 Cr | ₹55 Cr | ₹30 Cr | ₹44 Cr | ₹52 Cr | ₹51 Cr | ₹50 Cr | ₹50 Cr | ₹46 Cr | ₹43 Cr | ₹43 Cr | ₹40 Cr | ₹36 Cr | ₹35 Cr | ₹32 Cr | ₹39 Cr | ₹31 Cr | ₹29 Cr | ₹31 Cr | ₹29 Cr | ₹29 Cr | ₹31 Cr | ₹25 Cr | ₹28 Cr | ₹24 Cr | ₹29 Cr | ₹26 Cr |
| ₹4 Cr | ₹10 Cr | ₹9 Cr | ₹7 Cr | ₹8 Cr | ₹9 Cr | ₹8 Cr | ₹5 Cr | ₹7 Cr | ₹5 Cr | ₹4 Cr | ₹5 Cr | ₹4 Cr | ₹4 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹95 L | ₹23 L | ₹1 Cr | ₹1 Cr | ₹3 Cr | ₹3 Cr | ₹5 Cr | ₹4 Cr | ₹5 Cr | ₹41 L | ₹3 Cr | -₹71 L | -₹6 L | ₹1 Cr | ₹56 L | -₹25 L | -₹50 L | -₹2 Cr | ₹5 Cr | ₹2 Cr | ₹1 Cr | ₹94 L | ₹38 L | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹78 L | ₹63 L | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹53 L |
| ₹391 Cr | ₹387 Cr | ₹323 Cr | ₹190 Cr | ₹145 Cr | ₹146 Cr | ₹127 Cr | ₹131 Cr | ₹153 Cr | ₹147 Cr | ₹157 Cr | ₹143 Cr | ₹149 Cr | ₹136 Cr | ₹140 Cr | ₹111 Cr | ₹137 Cr | ₹137 Cr | ₹122 Cr | ₹106 Cr | ₹80 Cr | ₹66 Cr | ₹78 Cr | ₹64 Cr | ₹59 Cr | ₹36 Cr | ₹44 Cr | ₹55 Cr | ₹50 Cr | ₹50 Cr | ₹52 Cr | ₹47 Cr | ₹43 Cr | ₹42 Cr | ₹38 Cr | ₹40 Cr | ₹37 Cr | ₹33 Cr | ₹40 Cr | ₹32 Cr | ₹31 Cr | ₹33 Cr | ₹30 Cr | ₹31 Cr | ₹32 Cr | ₹26 Cr | ₹30 Cr | ₹25 Cr | ₹30 Cr | ₹26 Cr |
| ₹333 Cr | ₹322 Cr | ₹274 Cr | ₹152 Cr | ₹110 Cr | ₹115 Cr | ₹101 Cr | ₹94 Cr | ₹112 Cr | ₹109 Cr | ₹117 Cr | ₹100 Cr | ₹108 Cr | ₹102 Cr | ₹106 Cr | ₹82 Cr | ₹110 Cr | ₹111 Cr | ₹101 Cr | ₹81 Cr | ₹64 Cr | ₹54 Cr | ₹63 Cr | ₹45 Cr | ₹45 Cr | ₹27 Cr | ₹36 Cr | ₹44 Cr | ₹41 Cr | ₹41 Cr | ₹42 Cr | ₹38 Cr | ₹36 Cr | ₹33 Cr | ₹32 Cr | ₹29 Cr | ₹27 Cr | ₹26 Cr | ₹30 Cr | ₹25 Cr | ₹23 Cr | ₹25 Cr | ₹21 Cr | ₹24 Cr | ₹25 Cr | ₹20 Cr | ₹22 Cr | ₹20 Cr | ₹26 Cr | ₹22 Cr |
| ₹63 Cr | ₹69 Cr | ₹53 Cr | ₹42 Cr | ₹39 Cr | ₹34 Cr | ₹29 Cr | ₹39 Cr | ₹43 Cr | ₹40 Cr | ₹42 Cr | ₹45 Cr | ₹42 Cr | ₹35 Cr | ₹35 Cr | ₹30 Cr | ₹28 Cr | ₹27 Cr | ₹22 Cr | ₹26 Cr | ₹16 Cr | ₹13 Cr | ₹16 Cr | ₹19 Cr | ₹14 Cr | ₹9 Cr | ₹8 Cr | ₹11 Cr | ₹9 Cr | ₹8 Cr | ₹10 Cr | ₹9 Cr | ₹8 Cr | ₹10 Cr | ₹6 Cr | ₹11 Cr | ₹10 Cr | ₹8 Cr | ₹10 Cr | ₹7 Cr | ₹8 Cr | ₹8 Cr | ₹9 Cr | ₹7 Cr | ₹8 Cr | ₹6 Cr | ₹8 Cr | ₹5 Cr | ₹4 Cr | ₹4 Cr |
| ₹2 Cr | ₹10 L | ₹63 L | ₹23 L | ₹34 L | ₹16 L | ₹40 L | ₹20 L | ₹22 L | ₹25 L | ₹59 L | ₹30 L | ₹26 L | ₹19 L | ₹26 L | ₹20 L | ₹23 L | ₹13 L | ₹21 L | ₹28 L | ₹21 L | ₹22 L | ₹25 L | ₹18 L | ₹15 L | ₹13 L | ₹16 L | ₹16 L | ₹17 L | ₹15 L | ₹27 L | ₹19 L | ₹30 L | ₹21 L | ₹17 L | ₹16 L | ₹13 L | ₹11 L | ₹10 L | ₹12 L | ₹8 L | ₹9 L | ₹10 L | ₹8 L | ₹8 L | ₹13 L | ₹8 L | ₹8 L | ₹8 L | ₹9 L |
| ₹57 Cr | ₹65 Cr | ₹48 Cr | ₹38 Cr | ₹35 Cr | ₹31 Cr | ₹26 Cr | ₹36 Cr | ₹41 Cr | ₹38 Cr | ₹40 Cr | ₹44 Cr | ₹40 Cr | ₹34 Cr | ₹33 Cr | ₹29 Cr | ₹26 Cr | ₹26 Cr | ₹21 Cr | ₹25 Cr | ₹15 Cr | ₹12 Cr | ₹15 Cr | ₹19 Cr | ₹13 Cr | ₹9 Cr | -₹6 Cr | ₹11 Cr | ₹9 Cr | ₹8 Cr | ₹9 Cr | ₹9 Cr | ₹7 Cr | ₹9 Cr | ₹6 Cr | ₹11 Cr | ₹10 Cr | ₹8 Cr | ₹10 Cr | ₹7 Cr | ₹8 Cr | ₹8 Cr | ₹8 Cr | ₹7 Cr | ₹7 Cr | ₹6 Cr | ₹8 Cr | ₹5 Cr | ₹4 Cr | ₹4 Cr |
| ₹45 Cr | ₹48 Cr | ₹44 Cr | ₹30 Cr | ₹26 Cr | ₹25 Cr | ₹20 Cr | ₹28 Cr | ₹32 Cr | ₹29 Cr | ₹30 Cr | ₹33 Cr | ₹31 Cr | ₹26 Cr | ₹26 Cr | ₹22 Cr | ₹21 Cr | ₹20 Cr | ₹17 Cr | ₹19 Cr | ₹11 Cr | ₹10 Cr | ₹12 Cr | ₹13 Cr | ₹11 Cr | ₹8 Cr | -₹6 Cr | ₹8 Cr | ₹7 Cr | ₹6 Cr | ₹7 Cr | ₹6 Cr | ₹5 Cr | ₹6 Cr | ₹3 Cr | ₹9 Cr | ₹7 Cr | ₹6 Cr | ₹7 Cr | ₹5 Cr | ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹5 Cr | ₹5 Cr | ₹4 Cr | ₹5 Cr | ₹4 Cr | ₹3 Cr | ₹3 Cr |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹116 Cr | ₹23 Cr | ₹22 Cr | ₹22 Cr | ₹22 Cr | ₹22 Cr | ₹22 Cr | ₹22 Cr | ₹22 Cr | ₹22 Cr | ₹22 Cr | ₹22 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr |
| ₹34 L | ₹81 L | ₹48 L | ₹28 L | ₹4 L | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹766 Cr | ₹708 Cr | ₹424 Cr | ₹326 Cr | ₹240 Cr | ₹187 Cr | ₹147 Cr | ₹137 Cr | ₹113 Cr | ₹90 Cr | ₹69 Cr | ₹54 Cr | ₹54 Cr | ₹47 Cr | ₹41 Cr |
| ₹766 Cr | ₹708 Cr | ₹424 Cr | ₹326 Cr | ₹240 Cr | ₹187 Cr | ₹147 Cr | ₹137 Cr | ₹113 Cr | ₹90 Cr | ₹69 Cr | ₹54 Cr | ₹54 Cr | ₹47 Cr | ₹41 Cr |
| ₹882 Cr | ₹731 Cr | ₹447 Cr | ₹349 Cr | ₹262 Cr | ₹209 Cr | ₹170 Cr | ₹159 Cr | ₹136 Cr | ₹112 Cr | ₹91 Cr | ₹76 Cr | ₹65 Cr | ₹58 Cr | ₹52 Cr |
| ₹57 Cr | ₹8 Cr | ₹6 Cr | ₹7 Cr | ₹7 Cr | ₹7 Cr | ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹7 Cr | ₹5 Cr | ₹5 Cr | ₹4 Cr | ₹4 Cr | ₹2 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹10 L | ₹22 L | ₹0 | ₹0 | ₹0 | ₹73 L | ₹3 Cr | ₹6 Cr |
| ₹4 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹8 Cr | ₹7 Cr | ₹4 Cr | ₹2 Cr | ₹1 Cr | ₹67 L | -₹54 L | ₹18 L | -₹16 L | -₹37 L | -₹48 L | -₹47 L | -₹41 L | -₹47 L | -₹52 L |
| ₹2 Cr | ₹2 Cr | ₹97 L | ₹1 Cr | ₹77 L | ₹52 L | ₹50 L | ₹45 L | ₹38 L | ₹23 L | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹9 L | ₹9 L | ₹35 L | ₹3 L | ₹14 L | ₹6 L | ₹6 L | ₹5 L | ₹4 L | ₹7 L | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹14 Cr | ₹9 Cr | ₹5 Cr | ₹3 Cr | ₹2 Cr | ₹1 Cr | ₹1 L | ₹78 L | ₹48 L | -₹7 L | -₹48 L | -₹47 L | ₹32 L | ₹3 Cr | ₹5 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹161 Cr | ₹57 Cr | ₹73 Cr | ₹47 Cr | ₹59 Cr | ₹37 Cr | ₹23 Cr | ₹21 Cr | ₹11 Cr | ₹15 Cr | ₹13 Cr | ₹14 Cr | ₹14 Cr | ₹13 Cr | ₹15 Cr |
| ₹36 Cr | ₹10 Cr | ₹11 Cr | ₹9 Cr | ₹7 Cr | ₹9 Cr | ₹5 Cr | ₹6 Cr | ₹3 Cr | ₹3 Cr | ₹51 L | ₹1 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr |
| ₹4 Cr | ₹22 L | ₹5 Cr | ₹7 Cr | ₹2 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹4 Cr | ₹1 Cr | ₹3 Cr | ₹1 Cr | ₹0 | ₹18 L | ₹22 L |
| ₹4 Cr | ₹37 L | ₹47 L | ₹36 L | ₹25 L | ₹15 L | ₹24 L | ₹28 L | ₹23 L | ₹7 L | ₹1 Cr | ₹3 Cr | ₹88 L | ₹66 L | ₹66 L |
| ₹205 Cr | ₹67 Cr | ₹89 Cr | ₹64 Cr | ₹68 Cr | ₹50 Cr | ₹31 Cr | ₹29 Cr | ₹19 Cr | ₹20 Cr | ₹18 Cr | ₹19 Cr | ₹18 Cr | ₹17 Cr | ₹18 Cr |
| ₹1159 Cr | ₹815 Cr | ₹548 Cr | ₹423 Cr | ₹339 Cr | ₹267 Cr | ₹207 Cr | ₹195 Cr | ₹161 Cr | ₹140 Cr | ₹114 Cr | ₹100 Cr | ₹87 Cr | ₹81 Cr | ₹78 Cr |
| ₹3 Cr | ₹6 Cr | ₹5 Cr | ₹1 Cr | ₹11 L | ₹26 L | ₹20 L | ₹11 L | ₹26 L | ₹31 L | ₹19 L | ₹18 L | ₹16 L | ₹51 L | ₹43 L |
| ₹8 Cr | ₹22 L | ₹5 Cr | ₹7 Cr | ₹2 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹5 Cr | ₹1 Cr | ₹3 Cr | ₹2 Cr | ₹4 Cr | ₹6 Cr | ₹8 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹355 Cr | ₹205 Cr | ₹155 Cr | ₹107 Cr | ₹87 Cr | ₹60 Cr | ₹40 Cr | ₹34 Cr | ₹27 Cr | ₹26 Cr | ₹22 Cr | ₹20 Cr | ₹16 Cr | ₹14 Cr | ₹12 Cr |
| ₹77 Cr | ₹26 Cr | ₹18 Cr | ₹12 Cr | ₹7 Cr | ₹5 Cr | ₹3 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr |
| ₹278 Cr | ₹179 Cr | ₹137 Cr | ₹95 Cr | ₹80 Cr | ₹56 Cr | ₹37 Cr | ₹32 Cr | ₹25 Cr | ₹23 Cr | ₹19 Cr | ₹18 Cr | ₹14 Cr | ₹12 Cr | ₹10 Cr |
| ₹2 Cr | ₹21 Cr | ₹0 | ₹36 L | ₹0 | ₹5 Cr | ₹63 L | ₹14 L | ₹12 L | ₹0 | ₹0 | ₹3 L | ₹0 | ₹0 | ₹0 |
| ₹290 Cr | ₹330 Cr | ₹108 Cr | ₹89 Cr | ₹17 Cr | ₹32 Cr | ₹44 Cr | ₹43 Cr | ₹53 Cr | ₹47 Cr | ₹39 Cr | ₹29 Cr | ₹20 L | ₹1,000 | ₹0 |
| ₹290 Cr | ₹330 Cr | ₹108 Cr | ₹89 Cr | ₹17 Cr | ₹32 Cr | ₹44 Cr | ₹43 Cr | ₹53 Cr | ₹47 Cr | ₹39 Cr | ₹29 Cr | ₹20 L | ₹1,000 | ₹0 |
| ₹11 Cr | ₹21 Cr | ₹13 Cr | ₹9 Cr | ₹6 Cr | ₹6 Cr | ₹7 Cr | ₹7 Cr | ₹6 Cr | ₹7 Cr | ₹6 Cr | ₹8 Cr | ₹8 Cr | ₹7 Cr | ₹6 Cr |
| ₹2 Cr | ₹2 Cr | ₹32 L | ₹1 Cr | ₹15 L | ₹17 L | ₹14 L | ₹13 L | ₹13 L | ₹2 L | ₹0 | ₹0 | ₹0 | ₹7 L | ₹16 L |
| ₹584 Cr | ₹554 Cr | ₹262 Cr | ₹199 Cr | ₹108 Cr | ₹101 Cr | ₹92 Cr | ₹86 Cr | ₹89 Cr | ₹81 Cr | ₹64 Cr | ₹55 Cr | ₹22 Cr | ₹20 Cr | ₹17 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹27 Cr | ₹0 | ₹39 Cr | ₹0 | ₹1,000 | ₹86 L | ₹8 Cr | ₹5 Cr | ₹2 Cr | ₹0 | ₹0 | ₹0 | ₹16 Cr | ₹21 Cr | ₹20 Cr |
| ₹155 Cr | ₹64 Cr | ₹50 Cr | ₹47 Cr | ₹60 Cr | ₹29 Cr | ₹21 Cr | ₹25 Cr | ₹21 Cr | ₹13 Cr | ₹11 Cr | ₹10 Cr | ₹11 Cr | ₹11 Cr | ₹10 Cr |
| ₹290 Cr | ₹116 Cr | ₹139 Cr | ₹101 Cr | ₹111 Cr | ₹83 Cr | ₹54 Cr | ₹49 Cr | ₹28 Cr | ₹29 Cr | ₹25 Cr | ₹22 Cr | ₹22 Cr | ₹17 Cr | ₹17 Cr |
| ₹46 Cr | ₹42 Cr | ₹40 Cr | ₹60 Cr | ₹38 Cr | ₹34 Cr | ₹18 Cr | ₹15 Cr | ₹8 Cr | ₹13 Cr | ₹9 Cr | ₹10 Cr | ₹13 Cr | ₹12 Cr | ₹12 Cr |
| ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹3 Cr | ₹2 Cr | ₹3 Cr | ₹5 Cr | ₹5 Cr | ₹3 Cr | ₹81 L | ₹13 L | ₹36 L | ₹72 L | ₹69 L | ₹90 L |
| ₹46 Cr | ₹27 Cr | ₹7 Cr | ₹5 Cr | ₹14 Cr | ₹9 Cr | ₹1 Cr | ₹2 Cr | ₹4 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr | ₹3 Cr | ₹54 L | ₹2 Cr |
| ₹568 Cr | ₹254 Cr | ₹279 Cr | ₹217 Cr | ₹225 Cr | ₹158 Cr | ₹108 Cr | ₹101 Cr | ₹65 Cr | ₹59 Cr | ₹50 Cr | ₹45 Cr | ₹65 Cr | ₹62 Cr | ₹61 Cr |
| ₹363 Cr | ₹187 Cr | ₹189 Cr | ₹153 Cr | ₹157 Cr | ₹109 Cr | ₹77 Cr | ₹72 Cr | ₹46 Cr | ₹39 Cr | ₹31 Cr | ₹26 Cr | ₹47 Cr | ₹45 Cr | ₹43 Cr |
| ₹1159 Cr | ₹815 Cr | ₹548 Cr | ₹423 Cr | ₹339 Cr | ₹267 Cr | ₹207 Cr | ₹195 Cr | ₹161 Cr | ₹140 Cr | ₹114 Cr | ₹100 Cr | ₹87 Cr | ₹81 Cr | ₹78 Cr |
| ₹8 | ₹64 | ₹40 | ₹31 | ₹24 | ₹19 | ₹15 | ₹14 | ₹12 | ₹10 | ₹8 | ₹34 | ₹58 | ₹52 | ₹46 |
| ₹8 | ₹6 | ₹40 | ₹31 | ₹24 | ₹19 | ₹15 | ₹14 | ₹12 | ₹10 | ₹8 | ₹7 | ₹6 | ₹5 | ₹5 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Cash & Cash Equivalent of Subsidiaries under liquidations
Effect of Foreign Exchange Fluctuations
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹153 Cr | ₹141 Cr | ₹158 Cr | ₹115 Cr | ₹73 Cr | ₹56 Cr | ₹22 Cr | ₹34 Cr | ₹34 Cr | ₹38 Cr | ₹29 Cr | ₹20 Cr | ₹11 Cr | ₹11 Cr | ₹9 Cr |
| -₹3 Cr | -₹12 Cr | -₹8 Cr | ₹90 L | -₹66 L | -₹13 Cr | ₹14 Cr | ₹79 L | -₹4 Cr | -₹8 Cr | -₹87 L | -₹3 Cr | -₹2 Cr | -₹2 Cr | -₹1 Cr |
| -₹151 Cr | -₹32 Cr | -₹14 Cr | ₹18 Cr | -₹42 Cr | -₹24 Cr | ₹64 L | -₹13 Cr | -₹15 Cr | -₹3 L | -₹4 Cr | ₹75 L | -₹5 Cr | -₹3 Cr | ₹61 L |
| -₹39 L | ₹98 Cr | ₹136 Cr | ₹134 Cr | ₹30 Cr | ₹19 Cr | ₹36 Cr | ₹22 Cr | ₹16 Cr | ₹31 Cr | ₹24 Cr | ₹18 Cr | ₹5 Cr | ₹7 Cr | ₹8 Cr |
| -₹24 Cr | ₹69 Cr | ₹97 Cr | ₹107 Cr | ₹13 Cr | ₹9 Cr | ₹28 Cr | ₹12 Cr | ₹6 Cr | ₹19 Cr | ₹14 Cr | ₹14 Cr | ₹1 Cr | ₹4 Cr | ₹5 Cr |
| ₹105 Cr | -₹273 Cr | -₹46 Cr | -₹102 Cr | -₹74 L | -₹7 Cr | -₹19 Cr | ₹4 Cr | -₹9 Cr | -₹11 Cr | -₹10 Cr | -₹12 Cr | ₹12 Cr | ₹78 L | -₹10 Cr |
| -₹63 Cr | ₹176 Cr | -₹24 Cr | -₹6 Cr | -₹6 Cr | -₹4 Cr | -₹4 Cr | -₹3 Cr | -₹4 Cr | -₹6 Cr | -₹1 Cr | -₹3 Cr | -₹4 Cr | -₹3 Cr | ₹3 Cr |
| ₹19 Cr | -₹27 Cr | ₹27 Cr | -₹1 Cr | ₹7 Cr | -₹2 Cr | ₹5 Cr | ₹13 Cr | -₹7 Cr | ₹2 Cr | ₹2 Cr | -₹1 Cr | ₹9 Cr | ₹2 Cr | -₹2 Cr |
| ₹29 Cr | ₹56 Cr | ₹30 Cr | ₹29 Cr | ₹21 Cr | ₹23 Cr | ₹17 Cr | ₹4 Cr | ₹7 Cr | ₹9 Cr | ₹9 Cr | ₹12 Cr | ₹3 Cr | ₹1 Cr | ₹39 L |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹2,986 | ₹0 | ₹1 Cr |
| ₹8 Cr | -₹56 L | -₹61 L | ₹2 Cr | ₹1 Cr | -₹71 L | ₹38 L | ₹82 L | ₹4 Cr | -₹3 Cr | -₹3 Cr | -₹1 Cr | -₹41 L | -₹13 L | ₹1 Cr |
| ₹56 Cr | ₹29 Cr | ₹56 Cr | ₹30 Cr | ₹29 Cr | ₹21 Cr | ₹23 Cr | ₹17 Cr | ₹4 Cr | ₹8 Cr | ₹9 Cr | ₹9 Cr | ₹12 Cr | ₹3 Cr | ₹1 Cr |
Fundamental Ratios
Consolidated
Standalone

No results found
Fineotex Chemical Share Price
44.82+0.00 (-0.49%)
+82.05% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 3
Bearish signals: 6 out of 9 oscillators
RSI
35.28Sell
STOCH %K
9.37Buy
MACD Level(12,26)
-1.88Sell
Ultimate Oscillator
34.70Sell
Aroon Oscillator
-96.00Sell
BOP
-0.02Sell
CCI
-146.95Buy
Williams %R
-90.63Buy
Momentum
-3.68Sell
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 2
Bearish signals: 7 out of 9 moving averages
EMA 9
47.86Sell
SMA 9
49.02Sell
EMA 21
49.98Sell
SMA 21
49.75Sell
EMA 50
50.86Sell
SMA 50
53.69Sell
EMA 200
41.69Buy
SMA 200
38.19Buy
WMA 20
49.35Sell
Pivot
Pivot
Classic
Resistance 5
53.02
Resistance 4
50.98
Resistance 3
48.94
Resistance 2
46.90
Resistance 1
45.97
Pivot
44.86
Support 1
43.93
Support 2
42.82
Support 3
40.78
Support 4
38.74
Support 5
36.70
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Fineotex Chemical Share Price
44.82+0.00 (-0.49%)
+82.05% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| 62.30% | 62.30% | 62.30% | 62.57% | 62.88% | 62.88% |
| 2.01% | 3.16% | 2.92% | 2.53% | 2.35% | 2.51% |
| 0.17% | 0.08% | 0.00% | 0.00% | 0.00% | 0.09% |
| 1.46% | 1.27% | 1.27% | 1.28% | 1.63% | 3.08% |
| 34.06% | 33.19% | 33.51% | 33.62% | 33.14% | 31.44% |
Bulk & block deals
Name
Junomoneta Finsol Private Limited
Junomoneta Finsol Private Limited
Hrti Private Limited
Hrti Private Limited
Qe Securities Llp
Junomoneta Finsol Private Limited
Junomoneta Finsol Private Limited
Qe Securities Llp
Hrti Private Limited
Qe Securities Llp
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 25 May 2026 | Purchase | 30.42 Cr | ₹37.02 | 82.18 L | Bulk | 0.705723 | NSE |
| 25 May 2026 | Sell | 30.37 Cr | ₹37.04 | 81.99 L | Bulk | 0.704102 | NSE |
| 25 May 2026 | Sell | 27.69 Cr | ₹36.80 | 75.24 L | Bulk | 0.646132 | NSE |
| 25 May 2026 | Purchase | 25.43 Cr | ₹36.60 | 69.47 L | Bulk | 0.596546 | NSE |
| 20 May 2026 | Sell | 20.50 Cr | ₹34.29 | 59.77 L | Bulk | 0.513269 | NSE |
| 20 May 2026 | Sell | 20.90 Cr | ₹34.39 | 60.77 L | Bulk | 0.521893 | NSE |
| 20 May 2026 | Purchase | 20.71 Cr | ₹34.37 | 60.26 L | Bulk | 0.51749 | NSE |
| 20 May 2026 | Purchase | 20.22 Cr | ₹34.42 | 58.73 L | Bulk | 0.504367 | NSE |
| 19 May 2026 | Sell | 19.49 Cr | ₹32.91 | 59.22 L | Bulk | 0.50857 | NSE |
| 19 May 2026 | Sell | 26.86 Cr | ₹33.13 | 81.07 L | Bulk | 0.696162 | NSE |
Insider trading & SAST
Client name
Aarti Mitesh Jhunjhunwala
Mr. Sanjay Tibrewala
Sanjay Tibrewala
Surendra Tibrewala (Revised)
Surendra Tibrewala (Revised)
Aarti Mitesh Tibrewala
Surendra Tibrewala
Surendra Tibrewala
Aarti Mitesh Jhunjhunwala
Surendra Tibrewala
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 29 Mar 2025 | Promoter | Acquisition | 0.003491 | 0.07 | 9.52 L | ₹238.12 | 4 K | 28 Mar 2025 | Market Purchase | 85,050 | Insider Trading | — | Equity Shares |
| 06 Mar 2025 | Promoter | Acquisition | 0.017456 | 3.02 | 47.32 L | ₹236.58 | 20 K | 06 Mar 2025 | Market Purchase | 34,54,990 | Insider Trading | — | Equity Shares |
| 23 Mar 2023 | Promoter & Director | Acquisition | 0.036118 | 3.1 | 89.60 L | ₹224 | 40 K | 22 Mar 2023 | Market Purchase | 34,34,990 | Insider Trading | — | Equity Shares |
| 26 Dec 2022 | Promoter & Director | Acquisition | 0.010203 | 54.97 | 30.21 L | ₹267.37 | 11.30 K | 15 Dec 2022 | Market Purchase | 6,08,78,130 | Insider Trading | — | Equity Shares |
| 26 Dec 2022 | Promoter & Director | Acquisition | 0.006913 | 54.98 | 20.40 L | ₹266.48 | 7.66 K | 15 Dec 2022 | Market Purchase | 6,08,85,786 | Insider Trading | — | Equity Shares |
| 20 Dec 2022 | Promoter | Acquisition | 0.01 | 0.07 | 0 | — | 15 K | 15 Dec 2022 | Market | 81,050 | SAST | 29(2) | — |
| 20 Dec 2022 | Promoter | Acquisition | 0.02 | 54.98 | 0 | — | 19 K | 15 Dec 2022 | Market | 6,08,85,830 | SAST | 29(2) | — |
| 15 Dec 2022 | Promoter & Director | Acquisition | 0.006953 | 54.98 | 20.52 L | ₹266.48 | 7.70 K | 15 Dec 2022 | Market Purchase | 6,08,85,830 | Insider Trading | — | Equity Shares |
| 15 Dec 2022 | Promoter & Director | Acquisition | 0.013544 | 0.07 | 40.16 L | ₹267.71 | 15 K | 15 Dec 2022 | Market Purchase | 81,050 | Insider Trading | — | Equity Shares |
| 15 Dec 2022 | Promoter & Director | Acquisition | 0.010203 | 54.97 | 30.21 L | ₹267.37 | 11.30 K | 15 Dec 2022 | Market Purchase | 6,08,78,130 | Insider Trading | — | Equity Shares |
Fineotex Chemical Share Price
44.82+0.00 (-0.49%)
+82.05% past 1 Year
Fineotex Chemical Ltd is engaged in the manufacturing of Specialty Chemicals and Enzymes for various industries .The company manufactures and trade in Specialty Chemicals and Enzymes for Textile & Garment
Corporate Actions
Date
Type
Details
Company details
Fineotex Chemical Share Price
44.82+0.00 (-0.49%)
+82.05% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
Fineotex Chemical Share Price
44.82+0.00 (-0.49%)
+82.05% past 1 Year
News
1 of 20
ResultFCL13 Nov 2026
Fineotex Chemical reported Q2 FY27 consolidated revenue from operations of Rs 387.65 crores, up 181.5% year on year, while total income stood at Rs 391.41 crores, compared with Rs 145.43 crores in Q2 FY26. Operating EBITDA increased 92.0% year on year to Rs 59.59 crores from Rs 31.03 crores. Profit after tax rose 70.8% to Rs 44.55 crores from Rs 26.08 crores.
The operating EBITDA margin declined to 15.37% from 22.53% a year earlier, indicating margin compression despite strong revenue and earnings growth. EBITDA was broadly stable sequentially against Rs 59.14 crores in Q1 FY27, while the margin was slightly lower than the preceding quarter. The results indicate robust business expansion, accompanied by dilution in operating profitability.
Fineotex Chemical Reports Strong Second Quarter Profit Growth
ResultFCL13 Nov 2026
Fineotex Chemical reported consolidated Q2 FY27 total income of Rs 391.41 crores, compared with Rs 145.43 crores a year earlier, representing 169.1 percent YoY growth. Operating EBITDA increased to Rs 59.59 crores from Rs 31.03 crores, up 92.0 percent YoY, while the operating EBITDA margin declined to approximately 15.2 percent from 21.3 percent. Consolidated profit after tax rose to Rs 44.55 crores from Rs 26.08 crores, an increase of 70.8 percent YoY. The result indicates strong year-on-year earnings growth, although profitability margins moderated against the prior-year quarter. No street consensus, management guidance, or market reaction was provided.
Fineotex Chemical Reports Strong Q2 Revenue Growth With Higher Profitability
ResultFCL13 Nov 2026
Fineotex Chemical reported Q2 FY27 revenue from operations of Rs 387.65 crores, compared with Rs 137.71 crores a year earlier, representing 181.5% YoY growth. Total income increased to Rs 391.41 crores from Rs 145.43 crores, up 169.1% YoY. Operating EBITDA rose 92.0% YoY to Rs 59.59 crores from Rs 31.03 crores, while EBITDA margin moderated to approximately 15.4% from 22.5%.
Consolidated PAT increased 70.8% YoY to Rs 44.55 crores from Rs 26.08 crores. Revenue from operations grew approximately 2.9% QoQ from Rs 376.63 crores, while operating EBITDA increased marginally from Rs 59.15 crores. Net profit margin remained below the year-earlier level despite substantial revenue and earnings growth. The results indicate strong scale-up in Fineotex Chemical's specialty chemicals business.
Fineotex Chemical reports Profit after tax of 21.23 Crores, in the September 2026 quarter
ResultFCL13 Nov 2026
NULL
Fineotex Chemical schedules analyst and investor meeting on September 11, 8 am
Stock NewsFCL8 Sept 2026
Fineotex Chemical has informed the market that it will hold a meeting with analysts and investors on September 11 at 8 am. The planned interaction appears to be part of the company’s regular engagement with the investor and analyst community, aimed at providing updates on business operations, financial performance, strategic priorities, and industry dynamics. Such meetings typically involve management commentary on recent developments, demand trends across key end markets, input cost environment, and the company’s growth plans, including product pipeline, capacity utilisation, and geographic expansion strategy. Participants may also seek clarity on margins, capital allocation, and any ongoing or planned capital expenditure, as well as the company’s outlook for revenue growth and profitability over the medium term.
While the exact agenda, format, and duration of the September 11 interaction have not been detailed in the available context, the announcement indicates continued emphasis by Fineotex Chemical on transparent communication and sustained engagement with market participants. This kind of scheduled meeting is generally considered a routine corporate event, unless accompanied by explicit guidance changes, material disclosures on mergers and acquisitions, large capex commitments, or significant regulatory developments. In the absence of such additional information, the market is likely to treat the interaction as a standard investor relations activity designed to enhance understanding of the company’s fundamentals rather than a signal of any immediate, material change in earnings trajectory, leverage profile, or competitive position.
Fineotex Chemical forms Delaware step-down unit for specialty chemicals expansion
Stock NewsFCL2 Sept 2026
Fineotex Chemical, through its subsidiary Fineotex Biotex Healthguard FZE, has established a new entity named Fineotex Holdings Inc. in the US state of Delaware as a fully owned step-down subsidiary. The move is aimed at exploring opportunities in specialty chemicals and other growth areas, indicating a strategic push to expand its international corporate structure and presence in advanced chemical segments. By creating a holding company framework in a global jurisdiction, the group may seek to facilitate future investments, collaborations, or acquisitions in overseas markets, particularly in high-margin specialty chemical domains.
The new Delaware-based step-down subsidiary is expected to provide Fineotex Chemical with enhanced flexibility in structuring global operations, potentially improving access to international customers, technology partnerships, and funding channels. This expansion aligns with broader industry trends where Indian specialty chemical companies are increasingly setting up entities in key global jurisdictions to better serve multinational clients and integrate into global value chains. While no financial details, capital commitment, or specific project plans have been disclosed in the context provided, the formation of Fineotex Holdings Inc. suggests a medium- to long-term growth orientation rather than an immediate earnings event. The development could, over time, support diversification of revenue streams and strengthen Fineotex Chemical’s positioning in niche specialty chemical applications, contingent on successful execution of its international growth strategy.
Fineotex Chemical Q1 EBITDA surges YoY, margin compresses on lower spreads
ResultFCL23 Jul 2026
Fineotex Chemical reported a strong year-on-year improvement in operating profitability for the latest reported quarter, with Q1 EBITDA coming in at Rs 59.10 crores versus Rs 25.20 crores in the same quarter last year, indicating a robust expansion in absolute operating earnings driven by business growth and operating leverage. This sharp increase in EBITDA suggests that the company has scaled its operations effectively compared with the prior year period, even though detailed revenue and PAT figures are not available in the given context.
Despite the strong jump in absolute EBITDA, the Q1 EBITDA margin declined to 15.70% from 18.38% on a year-on-year basis, pointing to margin compression. This indicates that input costs, pricing, or mix effects have weighed on overall profitability in percentage terms, even as the company has grown its operating profit pool significantly in rupee terms. The lower margin suggests that the company may be operating in a more competitive or cost-intensive environment compared with the previous year, potentially due to raw material dynamics or changes in product or geographic mix.
In the absence of disclosed revenue, PAT, or consensus street expectations in the provided context, the focus remains on the sharp YoY increase in EBITDA and simultaneous decline in EBITDA margin as the key drivers of the result narrative. There is no information given about management commentary, forward-looking guidance, or immediate stock price reaction, so any implications for future earnings trajectory or near-term market performance must be interpreted strictly within the bounds of the reported operating performance metrics. Overall, the result snapshot reflects a quarter of strong operating profit growth in absolute terms accompanied by tighter margins at Fineotex Chemical, which investors will likely assess in conjunction with broader sectoral cost and demand trends.
Fineotex Chemical reports Q1 revenue of Rs 377.00 crores, up sharply year on year
ResultFCL23 Jul 2026
Fineotex Chemical reported Q1 revenue of Rs 377.00 crores versus Rs 137.00 crores in the same period last year, indicating a strong year on year increase in top line. The provided update does not include EBITDA, PAT, margin data, quarterly comparison, or management commentary, so those metrics are not stated here.
Based on the available information, the result points to a materially stronger revenue performance for the quarter. No consensus estimates, profit figures, or stock reaction are provided in the context, so the assessment is limited to the reported sales growth only.
Fineotex Chemical Q1 consolidated net profit rises sharply year-on-year
ResultFCL23 Jul 2026
Fineotex Chemical reported a strong improvement in profitability for the latest quarter, with Q1 consolidated net profit coming in at Rs 38.40 crores compared with Rs 24.80 crores in the same quarter last year. This represents a robust year-on-year increase in profit after tax, indicating healthy operational performance and better earnings scalability on a consolidated basis. The sharp rise in net profit suggests improved efficiency, possible gains in operating leverage, and favourable business dynamics in its core specialty chemicals and textile chemicals segments, although specific segmental details are not provided in the context.
Detailed revenue, EBITDA and margin figures for the quarter are not available in the given information, so trends in operating margin and net margin cannot be quantified. Similarly, the context does not provide quarter-on-quarter comparisons, street expectations, or consensus estimates, making it impossible to assess whether the results were above or below analyst forecasts. No management commentary, guidance on future quarters, capex plans, or demand outlook is mentioned, and there is no data on stock price reaction, trading volumes, or F&O positioning around the result date. In absence of verified additional metrics, the focus remains on the significant year-on-year increase in consolidated net profit, which indicates that Fineotex Chemical delivered a clearly stronger earnings performance compared to the same quarter of the previous financial year.
Fineotex Chemical’s arm expands Texas capacity by 150 MM lbs/year
Stock NewsFCL8 Jun 2026
The expansion has enhanced the company's ability to meet the growing demand for specialty chemicals across domestic and international markets
Fineotex Chemical informs about press release
Stock NewsFCL8 Jun 2026
NULL
Fineotex Chemical expands manufacturing capacity through strategic facility upgrade
Stock NewsFCL8 Jun 2026
Fineotex Chemical has announced a strategic expansion of its manufacturing facility, aimed at significantly enhancing its production capacity. The company will increase the facility's total manufacturing capacity from 20.00 crores pounds per year to 35.00 crores pounds per year. This represents a capacity addition of 15.00 crores pounds annually, or a 75 percent increase over the existing installed base. The move underscores management's focus on scaling operations to meet growing demand across its end-user industries and to strengthen its competitive positioning in the specialty chemicals space.
From a financial and strategic perspective, the expanded capacity can support higher revenue growth over the medium term, subject to successful ramp-up and utilization levels. Operating leverage may improve if incremental volumes are absorbed without a commensurate rise in fixed costs, potentially aiding margins over time. The expansion is also likely to provide better flexibility in servicing large orders, enabling Fineotex Chemical to deepen relationships with key customers and possibly gain market share in select product segments. While the announcement highlights the quantum of capacity enhancement, it does not specify the associated capex outlay, timeline to reach optimal utilization, or funding mix, which are key variables for assessing leverage and near-term return ratios. No immediate information is available in the provided context on stock price reaction, regulatory approvals, or any concurrent corporate actions such as buybacks, dividends, or stake sales. Overall, the development is operationally positive as it meaningfully lifts the company’s manufacturing capability, but the full earnings impact will depend on execution, demand conditions, and the pace at which the new capacity is absorbed into the market.
Fineotex Chemical boosts US subsidiary Texas plant capacity significantly
Stock NewsFCL8 Jun 2026
Fineotex Chemical has announced that its group has enhanced production capabilities at its Texas manufacturing facility operated through its US subsidiary. The company has increased the plant’s installed capacity by 15.00 crores pounds per annum, marking a notable scaling up of its international manufacturing footprint. This expansion indicates a strategic focus on strengthening overseas operations and leveraging demand in North American and global markets where speciality chemicals and performance chemicals see consistent industrial usage.
The sizeable capacity addition at the Texas plant is likely aimed at meeting higher order inflows from existing and potential customers, improving supply reliability and reducing lead times for export markets. By expanding through its US subsidiary, Fineotex Chemical can be better positioned to serve key end-user industries located in and around the US, potentially supporting volume growth and operational efficiencies over the medium term. The move may also aid in de-risking geographic concentration of production and diversifying revenue streams beyond India. While immediate financial metrics or order visibility linked to this expansion are not disclosed in the available context, the step reflects a growth-oriented capital deployment approach by the group and underscores management’s confidence in the demand outlook for its product portfolio.
Fineotex Chemical Q4 EBITDA doubles YoY but operating margin contracts sharply
ResultFCL15 May 2026
Fineotex Chemical reported a strong year-on-year improvement in operating profitability for the fourth quarter, led by a sharp rise in absolute EBITDA. Q4 EBITDA came in at Rs 43.70 crores versus Rs 21.30 crores in the corresponding period last year, indicating a substantial expansion in operating profit levels despite a challenging input-cost environment. This more than twofold increase in EBITDA suggests healthy scale-up in operations, improved contribution from key product lines, or better operating leverage across its chemical portfolio serving textiles, home care, hygiene, and allied segments. However, granular revenue and profit after tax figures are not available in the given context, limiting a full assessment of overall financial performance for the quarter.
Despite the strong absolute EBITDA growth, Fineotex Chemical’s operating profitability ratios showed some pressure. The Q4 EBITDA margin declined to 14 percent from 17.77 percent on a year-on-year basis. This margin compression indicates that growth in operating costs or changes in product mix outpaced the growth in top line, even as the company delivered higher absolute operating profits. The lower margin could reflect higher raw material costs, pricing pressure in certain client segments, or increased overheads linked to capacity expansion and growth initiatives. The combination of robust EBITDA growth and weaker margin suggests that the company may be prioritising volume expansion or market share gains over near-term margin preservation.
In the absence of street consensus estimates, revenue data, PAT numbers, or management commentary, it is difficult to fully benchmark these results against market expectations. Nevertheless, doubling of EBITDA on a year-on-year basis is a notable operational positive, partially offset by the decline in margin. No information is available on immediate stock price reaction or guidance from management in the provided context, and there is no explicit indication of any broader sector or macro implications arising from this single-company quarterly result.
Fineotex Chemical reports Profit after tax of 21.13 Crores, in the March 2026 quarter
ResultFCL15 May 2026
NULL
Fineotex Chemical Q4 profit and revenue surge sharply on strong year-on-year growth
ResultFCL15 May 2026
Fineotex Chemical reported a strong year-on-year performance for the fourth quarter, driven by a sharp increase in both revenue and profitability. Q4 consolidated net profit rose to Rs 31.60 crores from Rs 20.00 crores in the corresponding quarter last year, indicating a robust expansion in bottom line. This absolute increase in profit reflects improved operating leverage and better earnings scalability on a significantly higher revenue base.
On the top line, Q4 revenue surged to Rs 314.00 crores compared with Rs 120.00 crores in the same period a year ago, more than doubling the company’s turnover year-on-year. This substantial growth suggests strong demand momentum across its product portfolio and possibly higher contribution from both domestic and export markets, although the exact mix is not specified in the available context. The magnitude of revenue growth far outpaces the growth in net profit, implying that while profitability has improved in absolute terms, margin dynamics would need more detailed disclosure to assess whether cost pressures, product mix changes or investments in capacity and distribution have partially offset operating gains.
No information is provided on EBITDA, operating margin, net margin percentages, quarter-on-quarter trends, or management guidance, and there is no reference to market expectations or consensus estimates. Similarly, there is no data in the given context on stock price reaction, F&O positioning, or institutional flows. Based solely on the disclosed figures, the results indicate strong year-on-year operational and financial traction, anchored by a significant jump in revenue and a healthy increase in net profit on a consolidated basis.
Fineotex Chemical Acquires CrudeChem Technologies, Expands US Oilfield Chemicals Platform
Stock NewsFCL25 Mar 2026
Fineotex Chemical Limited (FCL) has acquired a controlling stake in CrudeChem Technologies Group, a US-based specialty chemical manufacturer, through a multi-entity acquisition totaling approximately Rs 210-215 crores (USD 26 million equivalent). The transaction, completed on December 9, 2025, strengthens FCL's position in North American oilfield chemicals, particularly in Texas, and provides immediate access to advanced technical capabilities and established customer relationships with leading global energy producers.
CrudeChem Technologies specializes in advanced chemical fluid additives and comprehensive oilfield chemical solutions, with world-class laboratories and manufacturing facilities located in Midland and Brookshire, Texas. The company generated approximately USD 68 million in annual revenue, demonstrating strong market acceptance and customer connectivity. This acquisition aligns with FCL's strategic objective to build a USD 200 million oilfield specialty chemicals platform within the coming years, leveraging demand in oilfield production, stimulation, and water treatment segments.
The acquisition is structured as a controlling stake investment with plans for gradual increase in ownership and capital deployment over subsequent years. All deals were cash-based and sized according to each entity's operational scale. FCL's expansion strategy strengthens its technological positioning in the high-value, technologically demanding global specialty chemicals market while enabling cross-regional product leverage and scalable growth. The transaction is expected to be earnings-accretive and contribute to revenue growth and margin expansion.
FCL reported a 46 percent increase in revenue for Q3 FY2026, driven by strong demand and strategic international expansion initiatives. This acquisition represents a transformative step in FCL's journey toward global expansion and technological leadership in high-performance and sustainable chemical solutions for the oil and gas industry.
CrudeChem Technologies specializes in advanced chemical fluid additives and comprehensive oilfield chemical solutions, with world-class laboratories and manufacturing facilities located in Midland and Brookshire, Texas. The company generated approximately USD 68 million in annual revenue, demonstrating strong market acceptance and customer connectivity. This acquisition aligns with FCL's strategic objective to build a USD 200 million oilfield specialty chemicals platform within the coming years, leveraging demand in oilfield production, stimulation, and water treatment segments.
The acquisition is structured as a controlling stake investment with plans for gradual increase in ownership and capital deployment over subsequent years. All deals were cash-based and sized according to each entity's operational scale. FCL's expansion strategy strengthens its technological positioning in the high-value, technologically demanding global specialty chemicals market while enabling cross-regional product leverage and scalable growth. The transaction is expected to be earnings-accretive and contribute to revenue growth and margin expansion.
FCL reported a 46 percent increase in revenue for Q3 FY2026, driven by strong demand and strategic international expansion initiatives. This acquisition represents a transformative step in FCL's journey toward global expansion and technological leadership in high-performance and sustainable chemical solutions for the oil and gas industry.
Fineotex Chemical Q3 EBITDA Flat YoY at Rs 34.80 Crores with Margin Compression.
ResultFCL13 Feb 2026
Fineotex Chemical reported Q3 **EBITDA** of Rs 34.80 crores, marginally up from Rs 34.30 crores YoY. **EBITDA margin** declined to 18.96% from 27.24% YoY. Detailed results from Business Standard indicate revenue at Rs 137.07 crores, down 3.40% YoY but up 14.43% QoQ from Rs 119.79 crores. Operating profit rose 81.29% YoY to Rs 9.30 crores, though QoQ growth was 16.98%. Profit before tax fell 16.31% YoY to Rs 31.50 crores, while net profit declined 13.70% YoY to Rs 24.81 crores, with QoQ increase of 24.24%.
The company filed Q3FY26 monitoring agency report confirming compliant utilization of Rs 136.319 crores from July 2024 preferential issue proceeds, allocated to working capital (Rs 10.274 crores utilized), business expansion (Rs 124.481 crores), and general corporate purposes (Rs 1.564 crores). Earnings conference call scheduled for February 16, 2026.
Fineotex Chemical Q3FY26 Results: Revenue Up 42.86% YoY, Net Profit Down 4.71% YoY.
ResultFCL13 Feb 2026
Fineotex Chemical reported Q3FY26 consolidated results with net profit of Rs 26.30 crores, down 4.71% YoY from Rs 27.60 crores. Revenue rose sharply to Rs 180.00 crores, up 42.86% YoY from Rs 126.00 crores.
Key financial highlights include strong top-line growth driven by operational expansion, though profitability dipped marginally on a YoY basis. The company continues to deploy preferential issue proceeds compliantly, with INR 136.319 crores utilized across working capital (Rs 10.274 crores), business expansion (Rs 124.481 crores), and general corporate purposes (Rs 1.564 crores) as of December 31, 2025. ICRA confirmed no deviations from planned objects, with timelines on track for completion by September 2030.
Recent quarterly trends from other sources indicate QoQ improvements in operating profit (Rs 9.30 crores, +81.29% YoY), though some metrics show YoY declines in PBT and net profit per alternative filings. No street expectations or management guidance provided in the context. Stock reaction post-results shows +0.50% (1-day return).
Fineotex Chemical reports Profit after tax of 25.65 Crores, in the December 2025 quarter
ResultFCL13 Feb 2026
NULL

